INTRODUCTION
============

The overall 5-year survival rate for locally advanced (T4) gastric carcinoma patients is generally below 20%.^[@B1]^ Radical resection is considered the best approach for achieving better long-term survival for patients.^[@B2]-[@B4]^ For the locally advanced (T4) gastric cancer with adjacent organ infiltration, multi-organ resection is required to achieve curative resection (R0) with negative macroscopic and microscopic margins. However, the combined multi-organ resection has an associated high risk of morbidity and mortality.^[@B5]^ Aggressive surgical treatment and appropriate patient selection for the locally advanced gastric cancer remain controversial. And few studies have demonstrated the clinicopathologic characteristics and the prognostic factors for T4 gastric cancers.

In this study, multi-organ resection was defined as the simultaneous resection of the stomach and directly invaded organs. The curative (R0) resection was defined as the complete removal of cancer tissue with no residual tumor macroscopically or microscopically and no evidence of distant metastasis. The surgery date was considered to be the entry point. The aim of this retrospective study was to study the clinicopathologic characteristics in patients with T4 gastric cancers. We have also investigated the prognostic factors of survival, which may serve as indicators of what types of patients who should receive and benefit from multi-organ resection.

METHODOLOGY
===========

Four hundred sixty three (463) consecutive patients with gastric cancers were enrolled in this study. Prior written and informed consent was obtained from every patient and the study was approved by the ethics review board of the first affiliated hospital, Sun Yat-sen University. Among these patients, patients who were diagnosed with clinical T4 gastric carcinoma (cT4) that invaded adjacent organs, and underwent extended multiorgan resection were analyzed retrospectively. Diagnosis of T4 disease was based on clinical data, including computed tomography (CT) scan data, endoscopic ultrasonography (US), and intraoperative assessments.

Multi-organ resection was defined as the simultaneous resection of the stomach and directly invaded organs. The curative (R0) resection was defined as the complete removal of cancer tissue with no residual tumor macroscopically or microscopically and no evidence of distant metastasis. The surgery date was considered to be the entry point. The date of dead, or the most recent follow-up time if the patients were not dead, was defined as the end point of the study. The following patients were excluded: (i): patients who were lost to follow-up or without complete clinical data; (ii) patients who had undergone resection of the distal esophagus for proximal expansion of the tumor, splenectomy for lymph node dissection, or additional procedures owing to disorders other than tumor invasion.

Data including clinicopathologic features of patients, such as ages, gender, tumor locations, tumor diameters, gastrectomy types, Borrmann types, histologic types, depths of invasion, lymph node stage and TNM stage, were obtained from a prospectively recorded database and given in [Table-I](#T1){ref-type="table"}. Histological classification and staging were based on the 6^th^ edition of the UICC TNM classification.^[@B6]^

***Statistical analyses:***Statistic analysis was finished by The SPSS program version 13.0 for Windows (SPSS Inc, Chicago, IL, USA). The outcome of interest was the prognostic factors for T4 gastric cancers. All categorical data were presented as rate and continuous data were expressed as mean ± SD. The strata were defined by the clinicopathologic variables of interest, including ages, gender, tumor locations, tumor diameters, gastrectomy types, Borrmann types, histologic types, depth of invasion, lymph node stage and TNM stage. The Kaplan-Meier method was used to define survival-associated factors. Differences in survival were analyzed using the Log rank tests. All factors associated with survival with a probability value of 0.05 or less were selected for multivariate analysis. The Cox proportional hazards model (Cox's model) was used for multivariate analysis to define prognostic factors determining cancer related survival. Hazard ratios (HR) with 95% CI were obtained as a measurement of association. *P*value less than 0.05 was considered statistically significant.

RESULTS
=======

***Clinicopathologic characteristics:***Of the 463 patients with gastric cancers enrolled in this study, 64 patients were diagnosed with clinical T4 gastric carcinoma (cT4) that invaded adjacent organs, and underwent extended multi-organ resections. One patient, who was lost to follow-up, was excluded. Therefore, a total of 63 cases were included in the analysis.

The clinicopathologic characteristics of the 63 patients are given in [Table-I](#T1){ref-type="table"}. Their mean age was 56.6 ± 12.6 years, ranging between 35 and 84 years. These patients comprised 40 (63.5%) male and 23 (36.5%) female. The mean tumor diameter was 7.2 ± 4.2 cm. Sixteen patients (25.4%) underwent distal subtotal gastrectomy and 47 (74.6%) underwent total gastrectomy. The most common lesion site was the upper third (38.1%), and the most common type was Borrmann III (49.2%). Histopathologic examination confirmed pT4 disease in 25 patients (39.7%), while 38 (60.3%) patients were pT3. The most common pathological type was poor-undifferentiated (76.2%). Fifty-one (81.0%) patients had lymph node metastasis. Among them, 19 (30.2%) had pN1, 15 (23.8%) had pN2, and 17 (27.0%) had pN3 disease. Six (9.5%) patients were in stage II; 21 (33.3%) in stage III; and 36 (57.1%) in stage IV, according to the TNM classification. Thirty-one patients (49.2%) underwent single-organ resection, and 32 patients (50.8%) had two or more organs resected. Curative resection was carried out in 49 patients (77.8%) and noncurative resection performed in 14 patients (22.2%).

The median follow-up time was 13 months (range, 1-22 months). Kaplan-Meier analysis of the cumulative survival rate was 61.6% at one year after operation ([Fig.1](#F1){ref-type="fig"}). The median for survival time was 19.0 months. The 95 percent confidence interval (CI) is 11.08-26.91. Standard D2 lymph node dissections or D2 plus para-aortic lymph node dissections were performed in most surgeries with curative intent.

***Univariate analysis of clinicopathologic variables:***The effects of clinicopathologic variables on the overall survival rate were analyzed using the Kaplan-Meier method, and the results of the log-rank tests for each variable are given in [Table-II](#T2){ref-type="table"}. To identify the putative clinical variables that may be able to be used as indicators of survival rate, univariate analysis was performed. Univariate analysis identified two clinical variables associated with survival rate: tumor diameter (1-year survival rate: 75.0% among patients with tumor diameter≤7cm and 35.1% among patients with tumor diameter＞7cm; P =0 .012; [Fig.2](#F2){ref-type="fig"}), and curability (1-year survival rate: 68.2% among patients with curative resection and 41.9% among patients with noncurative resection; *P*=0 .030; [Fig.3](#F3){ref-type="fig"}).

***Multivariable analysis:*** [Table-III](#T3){ref-type="table"} shows the results of the final multivariable Cox proportional hazards model with only tumor diameter and curability. In this model, tumor diameter \> 7cm (HR, 3.589; 95% CI, 1.425-9.037; *P* = 0.007) was significantly associated with a lower survival rate, while curative resection (HR, 0.330; 95% CI, 0.139-0.784; *P* = .0.012) was significantly associated with a higher survival rate.

DISCUSSION
==========

Gastric cancer remains second leading cause of death in the world, accounting for 10% of newly diagnosed cancers.^[@B7],[@B8]^ Complete resection is the only potentially curative treatment. However, long-term survival after gastrectomy for locally advanced (T4) gastric cancer remains poor.^[@B9]^ Because of the associated high risk of postoperative morbidity and mortality, and the poor survival rate, radical gastrectomy with multiorgan resection is still a controversial question for patients with gastric cancer invading adjacent organs. Thus, the decision of whether or not to perform radical gastrectomy with multiorgan resection of invaded organs must be decided by the experienced surgeon and considering some prognostic factors.

###### 

Clinicopathologic characteristics of 63 Patients

  *Clinical variable*            *Mean or patients*   *SD or rate*
  ------------------------------ -------------------- --------------
  *Age*(y)                       56.6                 12.6
  *Gender*                                            
         Male                    40                   63.5%
         Female                  23                   36.5%
  *Tumor diameter*(cm)           7.2                  4.2
  *Tumor location*                                    
         Upper                   24                   38.1%
         Middle                  17                   27.0%
         Lower                   15                   23.8%
         Whole                   7                    11.1%
  *Operation type*                                    
         Subtotal gastrectomy    16                   25.4%
         Total gastrectomy       47                   74.6%
  *Borrmann type*                                     
         I and II                10                   15.9%
         III                     31                   49.2%
         IV                      22                   34.9%
  *Differentiation*                                   
         Well-moderate           15                   23.8%
         Poor-undifferentiated   48                   76.2%
  *Depth of invasion*                                 
         T3                      38                   60.3%
         T4                      25                   39.7%
  *N-stage*                                           
         N0                      12                   19.0%
         N1(1\~6)                19                   30.2%
         N2(7\~15)               15                   23.8%
         N3(≥16)                 17                   27.0%
  *TNM stage*                                         
         II                      6                    9.5%
         III                     21                   33.3%
         IV                      36                   57.1%
  *Number of organs resected*                         
         1                       31                   49.2%
         ≥2                      32                   50.8%
  *Curability*                                        
         Non-curative            14                   22.2%
         Curative                49                   77.8%

![Cumulative survival rates of patients with T4 gastric cancers.](pjms-29-581-g001){#F1}

###### 

Univariate analysis of potential prognostic factors for survival rate in patients with T4 gastric cancer

  *Variables*                    *1-yr survival rate (%)*   *Log-rank P*
  ------------------------------ -------------------------- --------------
         ＜65                    55.0                       0.799
         ≥65                     73.5                       
  *Gender*                                                  
         Male                    85.8                       0.731
         Female                  64.6                       
  *Tumor diameter (cm)\**                                   
         ≤7                      75.0                       0.012
         ＞7                     35.1                       
  *Operation type*                                          
         Subtotal gastrectomy    77.9                       0.579
         Total gastrectomy       56.0                       
  *Borrmann type*                                           
         I and II                76.2                       0.894
         III                     84.6                       
         IV                      63.9                       
  *Differentiation*                                         
         Well-moderate           91.7                       0.103
         Poor-undifferentiated   52.9                       
  *Depth of invasion*                                       
         T3                      62.8                       0.373
         T4                      60.5                       
  *N-stage*                                                 
        N0                       80.0                       0.263
        N1(1\~6)                 80.7                       
        N2(7\~15)                45.7                       
        N3(≥16)                  46.9                       
  *TNM stage*                                               
         II                      100                        0.105
     III                         60.6                       
     IV                          56.3                       
  *Number of organs resected*                               
            1                    66.3                       0.241
            ≥2                   56.6                       
  *Curability\**                                            
     Non-curative                41.9                       0.030
     Curative                    68.2                       

\*P value \<0.05

![Cumulative survival rates in relation to tumor diameters, together with the *P*value from the log-rank tests.](pjms-29-581-g002){#F2}

![**Fig.3** **:**Cumulative survival rates in relation to curability, together with the *P*value from the log-rank tests.](pjms-29-581-g003){#F3}

###### 

Multivariable Cox regression analysis of prognostic factors associated with survival time in patients with T4 gastric cancer

  *Clinical variable*   *Model coefficient*   *HR*    *95% CI for HR*   *P value*
  --------------------- --------------------- ------- ----------------- -----------
  ≤7                                          1.000                     
  \>7                   1.278                 3.589   1.425-9.037       0.007
  *Curability*                                                          
  Non-curative                                1.000                     
  Curative              -1.110                0.330   0.139-0.784       0.012

Note: HR, hazard ratio

In the current study, we presented many clinicopathologic variables of T4 gastric cancer, such as ages, gender, tumor locations, tumor diameters, gastrectomy types, Borrmann types, histologic types, depth of invasion, lymph node stage and TNM stage. The clinicopathologic characteristics of T4 gastric cancer in our patients were similar to those as reported previously.^[@B10],[@B11]^ Total gastrectomy was most common surgical procedure (74.6%). The most common pathological type was poor-undifferentiated (approximately, 77%) and more than 80% patients had lymph node metastasis.

We observed that only 25 patients (39.7%) were confirmed with pT4 disease by histopathologic examinations, while more than half of the patients were with pT3 disease. It could be difficult to correctly identify the T4 gastric cancer by computed tomography scan, endoscopic ultrasonography, and intraoperative assessments. Because many pT3 patients showed densely inflammatory adhesions between the cancer and adjacent organs without actual invasion, the positive predictive values of preoperative computed tomographic scans in assessing T4 stage were only 50%.^[@B12]^ In the current study, there was no significant difference in survival rates for histopathologic T stage (pT3 vs. pT4, p=0.373). This was consistent with results reported previously.^[@B4],[@B13],[@B14]^ Therefore, multi-organ resection was recommended for patients with clinical T4 gastric cancer for curative resection.

Analysis of prognostic factors for T4 patients treated with multi-organ resection might help to select the optimal candidates in the future. According to our multi-variate analyses, tumor size (≤ 7cm) and curability (R0) were long-term survival factors in patients with T4 gastric cancer, who underwent multi-organ resections. Small tumor size may be associated with well-moderate differentiation, early TNM stage, and curative resection, leading to a long-time survival. Many studied identified curability (R0) as a predominant factor influencing a good prognosis for patients with T4 gastric cancer^[@B15]^, which was conformed in our study. Therefore, multi-organ resection should be performed with curative intents in patients with no other incurable factors.

Ages, resection of more than one organ and lymph node metastasis, as prognostic factors in T4 gastric cancer, had been reported in some previous literature.^[@B16]-[@B20]^ In the present study, we could not confirm the effects of these factors. The reason may be this study was a small sample size, short-term study. It was difficult to get significant difference. So a large sample size, long-term study is needed to confirm the prognostic factors in the future. In conclusion, multi-organ resection was recommended for patients with clinical T4 gastric cancer for curative resection. Each patient should be given the chance of curative resection, especially the patients with tumor diameter ≤ 7 cm.
